These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10199687)

  • 21. Will converting naloxone to over-the-counter status increase pharmacy sales?
    Murphy SM; Morgan JR; Jeng PJ; Schackman BR
    Health Serv Res; 2019 Aug; 54(4):764-772. PubMed ID: 30790269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The availability of pharmacies in the United States: 2007-2015.
    Qato DM; Zenk S; Wilder J; Harrington R; Gaskin D; Alexander GC
    PLoS One; 2017; 12(8):e0183172. PubMed ID: 28813473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy preferred-provider organizations.
    Curtiss FR
    Am J Hosp Pharm; 1987 Aug; 44(8):1797-801. PubMed ID: 3631107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug utilization and cost in a Medicaid population: a simulation study of community vs. mail order pharmacy.
    Valluri S; Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL
    BMC Health Serv Res; 2007 Jul; 7():122. PubMed ID: 17663768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do Insurers With Greater Market Power Negotiate Consistently Lower Prices for Hospital Care? Evidence From Hospital Price Transparency Data.
    Wang Y; Meiselbach MK; Xu J; Bai G; Anderson G
    Med Care Res Rev; 2024 Feb; 81(1):78-84. PubMed ID: 37594219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consumer channeling by health insurers: natural experiments with preferred providers in the Dutch pharmacy market.
    Boonen LH; Schut FT; Koolman X
    Health Econ; 2008 Mar; 17(3):299-316. PubMed ID: 17647296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical care in community pharmacies: practice and research in the US.
    Christensen DB; Farris KB
    Ann Pharmacother; 2006; 40(7-8):1400-6. PubMed ID: 16868221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of prescription charges in a health maintenance organization.
    Karls TA; Peterson CR; Thielke TS
    Am J Hosp Pharm; 1989 Aug; 46(8):1562-6. PubMed ID: 2773960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Market structure and hospital-insurer bargaining in the Netherlands.
    Halbersma RS; Mikkers MC; Motchenkova E; Seinen I
    Eur J Health Econ; 2011 Dec; 12(6):589-603. PubMed ID: 20853127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of local competition on the willingness of community pharmacies to supply medication therapy management services.
    Brooks JM; Klepser DG; Urmie JM; Farris KB; Doucette WR
    J Health Hum Serv Adm; 2007; 30(1):4-27. PubMed ID: 17557694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geospatial analysis of statin adherence using pharmacy claims data in the state of Michigan.
    Erickson SR; Lin YN
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1208-15. PubMed ID: 25443514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation in drug prices at pharmacies: are prices higher in poorer areas?
    Gellad WF; Choudhry NK; Friedberg MW; Brookhart MA; Haas JS; Shrank WH
    Health Serv Res; 2009 Apr; 44(2 Pt 1):606-17. PubMed ID: 19178584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
    Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of racial and socioeconomic disparities in medication pricing and pharmacy access and services.
    Chisholm-Burns MA; Spivey CA; Gatwood J; Wiss A; Hohmeier K; Erickson SR
    Am J Health Syst Pharm; 2017 May; 74(10):653-668. PubMed ID: 28377378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Entry and competition of retail pharmacies: A case study of OTC drugs sales and ownership deregulation1.
    Bilka M; Duarte AP; Lábaj M
    Ceska Slov Farm; 2023; 72(1):11-20. PubMed ID: 36858976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and testing of performance measures for pharmacy services.
    Pillittere-Dugan D; Nau DP; McDonough K; Pierre Z
    J Am Pharm Assoc (2003); 2009; 49(2):212-9. PubMed ID: 19289348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mysteries of prescription pricing in retail pharmacies.
    Berki SE; Richards JW; Weeks HA
    Med Care; 1977 Mar; 15(3):241-50. PubMed ID: 846238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Financial Integration Between Physicians and Hospitals With Commercial Health Care Prices.
    Neprash HT; Chernew ME; Hicks AL; Gibson T; McWilliams JM
    JAMA Intern Med; 2015 Dec; 175(12):1932-9. PubMed ID: 26501217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H; Sorofman B; Manasse HR
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.